Norwest is a multi-stage, sector-diverse investment firm that backs companies from Seed through Growth, with strongest pattern recognition in enterprise software, consumer, and healthcare. The firm combines high-conviction early investing in exceptional teams with disciplined later-stage underwriting around efficient growth, customer love, and paths to profitability.
Evaluation weights
How much weight this firm places on each dimension. Totals 100%.
Revenue, growth, and unit economics
Size, timing, and competitive landscape
Founder experience and execution ability
Differentiation and technical quality
- Bias toward founder quality over perfect early metrics
- Comfort with early risk if team and market insight are exceptional
- Strong preference for efficient growth over vanity growth
- Favors businesses that can pair product love with disciplined scaling
Pitch difficulty
How hard it is to get a meeting and close funding from this firm.
- Funded / yr
- 52Deals closed in a typical year.
- Led / yr
- 18Rounds led in the last 12 months.
- Pitches / yr
- ~38792Decks reviewed in a typical year.
- Acceptance rate
- 0.1%Share of pitches that get funded.
Estimated — public data is not fully disclosed.
Why it's hard
- High emphasis on founder-market fit and execution quality
- Requires concrete evidence of customer love or unusually strong pre-launch insight
- Penalizes weak differentiation and shallow competitive understanding
- Applies disciplined scrutiny to unit economics and profitability path in later stages
Norwest is broad in stage coverage and can invest before launch, but it maintains a high bar on founder quality, customer love, differentiation, and operating discipline. Its flexibility on timing does not translate into looseness on judgment; the firm is willing to move early, yet only when conviction is strong across team, product, and market.
Green flags
What drives a yes for this firm.
- Exceptional founder-market fit with humility, insight, and execution ability
- Clear customer love shown through retention, engagement, NPS, or strong qualitative pull
- Thoughtful, iterative product development informed by customer testing
- Large or expanding market with credible differentiation
- Disciplined go-to-market and unit economics, especially as the business scales
Red flags
What kills deals and gets a fast no.
- Weak evidence that users truly care about the product
- Inability to explain differentiation or competitive dynamics clearly
- Sloppy thinking on CAC, payback, LTV:CAC, or scaling efficiency
- Growth-at-all-costs plans with no credible path to profitability
- Founders who appear uncoachable or disconnected from customer needs
How to win
Patterns that lead to successful pitches.
- Lead with why this team has unique insight and right to win
- Show real customer love using retention, engagement, NPS, or strong qualitative evidence
- Demonstrate rapid learning loops and product iteration based on customer feedback
- Present a sharp view of market structure, competitors, and differentiation
- For scaling companies, show efficient GTM with credible CAC payback and profitability trajectory
Fund strategy & identity
Who they are and how they operate.
- Invest across the full company lifecycle from Seed/Series A to Growth
- Lead or co-lead rounds where conviction is high
- Back strong teams even before launch when market insight is exceptional
- Use flexible underwriting rather than rigid metric cutoffs at early stage
- Scale capital meaningfully behind winners, from venture checks to large growth rounds
Firm identity
Investment focus
Industries, themes, and typical ARR expectations.
Industries
Investment themes
Typical check by stage
Typical ARR by stage
Investment thesis
Core beliefs and strategy behind their investing approach.
Norwest is a generalist, multi‑stage investor focused on enterprise/technology (including B2B SaaS), consumer, and healthcare/life‑sciences sectors. Its thesis is that enduring value is created by pairing strong founders with large, expanding markets and operational discipline. The firm invests globally but concentrates on North America, India, and Israel, leveraging local offices. It pursues the full capital continuum—from seed relationships and product validation to Series A/B scaling and later growth equity—deploying $1‑30 M in venture checks and $20‑200 M in growth equity. Norwest avoids rigid metric thresholds, instead looking for concrete evidence of customer love, iterative product development, and scalable unit economics. In growth equity it prioritises efficient growth (reasonable CAC payback, strong LTV:CAC) and paths to profitability.
Decision patterns
How they evaluate and make investment decisions.
Norwest repeatedly frames evaluation along three vectors—people, product, and market—with pronounced weight on founder‑market fit (“the best teams win”). It will invest at Series A even “well before the product launched” when it has conviction in the team’s insights, humility, customer empathy, and ability to execute. Signals that move Norwest to a “yes” at seed‑A include customers loving the product (strong NPS, retention, engagement), evidence the team listens and iterates quickly based on structured tests, and clear thinking about where/how to find customers (even if CACs aren’t fully known yet). Deal‑breakers are the inverse: weak or untested customer love; inability to articulate differentiation; superficial grasp of competitive dynamics; or poor/undisciplined unit‑economics thinking. In growth equity, Norwest stresses efficient top‑line growth, reasonable CAC payback, and healthy LTV:CAC, flagging “growth at all costs” without a path to profitability as a negative.
Risk appetite
Norwest is a high‑conviction but disciplined investor. It is comfortable leading or co‑leading early‑stage rounds and will back pre‑revenue or pre‑launch companies when the team, market opportunity, and differentiation are clear. In growth equity it prefers businesses with proven product‑market fit, efficient growth, and credible profitability, emphasizing CAC payback under 24 months (ideally under 12) and LTV:CAC of at least 2× (ideally 3×+). This reflects a moderate‑to‑aggressive risk posture: willing to take early technical/market risk on outstanding teams while insisting on disciplined go‑to‑market and unit‑economics as companies scale.
Notable investments
Key portfolio companies and why they fit the thesis.
- UdemyLeadGlobal marketplace and ed‑tech platform at scale; aligns with Norwest’s consumer/marketplaces and software thesis.
- ExabeamLeadSecurity analytics/SIEM innovation squarely in enterprise software/security; Norwest led the Series A.
- TalkspaceLeadDigital health/tele‑therapy in a large market; Norwest led the Series B.
- QualifiedLeadSalesforce‑ecosystem conversational marketing for B2B SaaS; Norwest led the Series A.
- EdiphiLeadConstruction‑tech estimating SaaS modernizing pre‑construction workflows; Norwest led the Series A.
- GongLeadCategory‑creating revenue‑intelligence platform (enterprise SaaS/AI); Norwest led Seed and A1.
- SpiffLeadNext‑gen commissions‑management SaaS for mid‑market/enterprise; Norwest led the Series A.
- ReplicantLeadVoice‑AI contact‑center automation fitting Norwest’s enterprise/AI thesis; Norwest led Seed and Series A.
- Red AccessLeadAgentless browser/SSE security solution core to Norwest’s Israel/enterprise security focus; Norwest led the Series A.
Co-invested with
Other firms in this catalog who've backed the same companies.
Partners
Full firm roster — key partners, partners, and the wider team.
Key partners
Jeff Crowe
Senior Managing Partner
Norwest
Senior Managing Partner at Norwest focused on venture investments in internet, consumer and software.
Jon Kossow
Managing Partner
Norwest
Managing Partner and Co-head of Growth Equity at Norwest.
Sonya Brown
General Partner
Norwest
General Partner and Co-head of Growth Equity at Norwest focused on consumer, retail, internet and business services.
Ran Ding
General Partner
Norwest
General Partner at Norwest co-leading B2B growth equity investments.
Dave Zilberman
General Partner
Norwest
Dave Zilberman is a General Partner at Norwest focused on venture investments in enterprise and infrastructure.
Partners
Promod Haque
Venture Partner
Norwest
Venture Partner and longtime Norwest investor focused on software, IT infrastructure, healthcare IT, and services.
Will McCallum
Principal, Head of Debt Capital Markets, Growth Equity
Norwest
Norwest growth equity principal leading debt capital markets and financing transactions.
Niren Shah
Managing Director and Head of Norwest India
Norwest
Head of Norwest India investing across Indian technology, fintech, internet, and consumer companies.
Casper de Clerq
Venture Partner
Norwest
Norwest healthcare Venture Partner focused on medical devices and digital health.
Lisa Wu
Partner
Norwest
Partner investing in consumer Internet, B2B application software, marketplaces, fintech, and proptech.
Assaf Harel
Partner
Norwest
Norwest Partner focused on Israeli-related multi-stage technology investments.
Scott Mitchell
Partner
Norwest
Growth equity partner focused on consumer, retail, e-commerce, food tech, business services, software, and media.
Irem Rami
Partner
Norwest
Healthcare partner investing in tech-enabled services, healthcare IT, digital health, and pharma services.
Zack Scott
General Partner
Norwest
Norwest healthcare GP investing across medtech, diagnostics, therapeutics, and healthcare services.
Scott Beechuk
Partner
Norwest
Enterprise software partner investing in AI, SaaS, CX, customer support, sales enablement, and commerce infrastructure.
Sean Jacobsohn
Partner
Norwest
Norwest partner investing in enterprise cloud, SaaS, AI-enabled software, marketplaces, and industry cloud.
Chris Scullin
Partner
Norwest
Growth equity partner focused on software, tech services, healthcare tech, and data businesses.
Dror Nahumi
General Partner
Norwest
General Partner investing in Israel-linked enterprise, cloud, SaaS, security, and AI companies.
Team
Sharvil Patel
Investment Advisor, Norwest India
Norwest
Norwest India investment advisor focused on venture and growth equity across Indian companies.
Amalia Mackenzie
Investor
Norwest
Norwest venture investor focused on consumer and enterprise software.
Lori Steffel
Investor
Norwest
Norwest growth equity investor focused on software and information services.
Owen Chun
Investor
Norwest
Norwest venture investor focused on enterprise software and infrastructure.
Krish Kapadia
Vice President, Norwest India
Norwest
Norwest India VP focused on early-stage and growth equity investments across Indian companies.
Amy Brand
Investor
Norwest
Norwest growth equity investor and former Barclays financial sponsors banker.
Apurva Oak
Investor
Norwest
Healthcare growth investor focused on software and services at Norwest.
Krista Jiranek
Investor
Norwest
Norwest growth equity investor with consumer investment banking experience from TD Cowen.
Ehi Akhirome
Investor
Norwest
Healthcare venture investor focused on therapeutics, medtech, diagnostics, and digital health.
Kayla Henderson
Investor
Norwest
Growth equity investor focused on technology, business services, media, and consumer.
Justin Zhang
Investor
Norwest
Healthcare venture investor focused on biopharma, digital health, medtech, and diagnostics.
Abishek Balakrishnan
Investor
Norwest
Norwest growth equity investor focused on healthcare services, IT, devices, and digital health.
Gabrielle Rush
Investor
Norwest
Norwest investor focused on consumer internet, marketplaces, SaaS, fintech, and digital commerce.
Matthew Uthupan
Investor
Norwest
Norwest growth equity investor focused on technology, business services, media, and consumer.
Quinton Cain
Investor
Norwest
Norwest growth equity investor focused on consumer, services, retail, franchises, and e-commerce.
JP McKeever
Investor
Norwest
Healthcare growth equity investor focused on services, pharma services, IT, medtech, and digital health.
Gabe Stauber
Vice President
Norwest
Norwest growth equity VP investing across multiple sectors.
Suketi Rathore
Investment Advisor, Norwest India
Norwest
Norwest India investment advisor focused on growth equity and early-stage Indian companies.
Max Zhang
Investor
Norwest
Norwest growth equity investor focused on technology, business services, media, and consumer.
Michael D'Arrigo
Growth Private Equity Investor
Norwest
Norwest growth private equity investor with prior Blue Collective and Quipli experience.
Cassie McHenry
Vice President
Norwest
Growth equity VP focused on software and technology investments.
Mary Miller
Business Development, Growth Equity Investing
Norwest
Norwest growth equity business development lead with prior SoftBank and TSG Consumer Partners experience.
Philip Fleischman
Vice President
Norwest
Norwest VP focused on healthcare growth equity across services, IT, pharma, and managed care.
Chris Sondej
Principal
Norwest
Growth equity principal investing in software, information services and tech-enabled services.
Suraj Shah
Vice President
Norwest
Norwest VP focused on healthcare venture investments across digital health, devices, diagnostics, and biopharma.
Ankit Prasad
Norwest India
Norwest
Norwest India investor focused on venture and growth equity across Indian companies.
Raghav Singodia
Investment Advisor, Norwest India
Norwest
Norwest India investment advisor focused on early-stage and growth equity investments.
Lauren (Beauchamp) James
Vice President
Norwest
Norwest VP focused on growth equity, with prior Jefferies consumer and retail banking experience.
Dawn Timan
Vice President
Norwest
Portfolio Success VP leading tax and regulatory compliance work at Norwest.
Olivia Meredith
Investor
Norwest
Norwest growth equity investor focused on technology, business services, media, and consumer.
Connor Pike
Principal
Norwest
Growth equity principal focused on products and services buyouts and minority investments.
Jordan Leites
Principal
Norwest
Norwest principal investing in venture deals across consumer, fintech, AI, and digital assets.
Daniel Andrud
Investor
Norwest
Growth equity investor focused on software and tech-enabled services.
Andrew Ellis
Investor
Norwest
Norwest growth equity investor focused on software and tech-enabled services.
David Glaser
Vice President
Norwest
Venture investor focused on enterprise and infrastructure companies.
John McNeil
Investor
Norwest
Healthcare venture investor focused on digital health, medtech, diagnostics, and biopharma.
Angela Johnson
Vice President
Norwest
Norwest growth equity VP focused on technology, business services, media, and consumer.
Brian Matesic, MD
Principal
Norwest
Life sciences investor backing early- to mid-stage biotech and medtech companies.
Gal Amran
Vice President
Norwest
Israel venture investor focused on enterprise, infrastructure, and consumer startups.
Jonah Lewis
Investor
Norwest
Growth equity investor focused on business services, consumer, media, and technology.
Jessica Yi
Vice President
Norwest
Enterprise and infrastructure venture investor at Norwest.
Sameer Kapur
Vice President
Norwest
Norwest VP focused on software and information services growth equity.
Aria Shah
Investment Professional
Norwest
Growth investment professional with healthcare and venture capital experience.
Ken Graham
Investor
Norwest
Norwest growth equity investor focused on consumer, e-commerce, retail, and business services.
Aidan Greenstein
Investor
Norwest
Norwest growth equity investor covering technology, business services, media, and consumer.
Anjini K.
Investor
Norwest
Norwest healthtech venture investor with prior Oscar Health and McKinsey experience.
Nikhil Goel
Investor
Norwest
Norwest venture investor focused on AI apps, agent infrastructure, data, and enterprise software.
Public voice
Notable statements and public positions.
- “We take pride in squinting our eyes and seeing the potential.” — Matt Howard, How to Ace Your Series A Fundraise.
- “Tactically speaking, we evaluate companies along three vectors: people, product, and market… On people: The best teams win.” — Matt Howard, How to Ace Your Series A Fundraise.
- “At Norwest we developed a new internal metric, ‘3GP’ (3 × revenue growth + profitability), which we believe better captures the value trade‑off between growth and profitability.” — Ran Ding, Keeping it 100: A Better Way of Assessing SaaS Performance than ‘Rule of 40’.
Similar firms
Firms with overlapping stage and industry focus.

NextView Ventures
2.4%
Bessemer Venture Partners
0.2%
Bling Capital
0.8%
